Comparison of Synchronous and Asynchronous Action Observation Therapy in Children With Cerebral P… (NCT07114731) | Clinical Trial Compass
CompletedNot Applicable
Comparison of Synchronous and Asynchronous Action Observation Therapy in Children With Cerebral Palsy
Turkey (Türkiye)22 participantsStarted 2025-08-04
Plain-language summary
The aim of this study is to compare the effects of synchronous and asynchronous action observation therapy (AOT) on balance, gait, and functional capacity in children with cerebral palsy (CP). CP is a neurodevelopmental disorder characterized by impairments in motor skills, particularly motor control and postural balance. By examining the contributions of synchronous (real-time) and asynchronous (delayed) AOT methods to motor performance, this study seeks to identify the most effective therapeutic approach for this population.
Who can participate
Age range
6 Years – 18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Voluntary participation of both the child and their family in the study
* Diagnosis of cerebral palsy with spastic clinical type, including hemiparetic and diparetic distribution
* Age between 6 and 18 years
* Classified as Level I or II according to the Gross Motor Function Classification System (GMFCS)
* Ability to comply with exercise interventions (based on medical report indicating normal mental level or "mild mental retardation")
* Ability to understand and speak Turkish
Exclusion Criteria:
* Presence of spasticity ≥3 in lower extremity muscle groups as measured by the Modified Ashworth Scale
* Inability to cooperate with verbal commands
* Presence of visual or hearing impairments
* Diagnosis of epilepsy or current use of antiepileptic medications
* Presence of joint contractures
* Botulinum toxin injection to the lower extremities within the past 6 months
* Undergoing orthopedic surgery within the past 6 months
* Presence of any additional systemic or neurological diseases
* Missing three consecutive rehabilitation sessions
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Gross Motor Function Measure - 88 (GMFM-88) - Dimensions D and E